Though there are currently few precise molecular mechanistic investigations on its involvement, it has been confirmed thus far that ATP1B3 plays a role in a number of malignancies and has the potential to become a new target for clinical therapy of cancer. The gene discussed is ATP1B3; the disease is cancer.